Professor, Obstetrics and Gynecology, New York University School of Medicine
Obstetrics & Gynecology
Dr. Steven S. Goldstein, MD
|
|
Give Review
Steven Goldstein practices Obstetrics & Gynecology. He went to medical school at NYU School of Medicine. He received 9 awards: "1st Place Winner Best of the Best Video Journal of Ob Gyn", "Outstanding Paper in Obstetrics", "Samuel Soffer Award - Outstanding Student in Urology", "Austen Colgate Scholar", "Who's Who", "Honors in Biology", "Phi Beta Kappa", "Fellow (FACOG)" and "Super Doctor". Steven Goldstein is also published. He has 99 publications published. The lastest publication: "Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women.' Steven Goldstein accepts all Medicare patients.
Publications
- Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system?
- Cystadenofibromas: Can transvaginal ultrasound appearance reduce some surgical interventions?
- Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American ...
- Why the product labeling for low-dose vaginal estrogen should be changed.
- Endometrial safety of ospemifene: results of the phase 2/3 clinical development program.
- Endometrial safety of ospemifene and the ability of transvaginal ultrasonography to detect small changes in endometrial thickness.
- Osteoporosis Risk Factors and Early Life-style Modifications to Decrease Disease Burden in Women.
- Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.
- Diagnostic criteria for nonviable pregnancy early in the first trimester.
- Transesophageal Echocardiographic Screening before Atrial Flutter Ablation: Is It Necessary for Patient Safety?
- Begin With the Basics: Role of 3-Dimensional Sonography as a First-line Imaging Technique in the Cost-effective Evaluation of Gynecologic Pelvic Disease.
- Office diagnosis and management of abnormal uterine bleeding.
- Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass.
- Bone health medications: research questions versus clinical choices.
- Introduction to a special section on the causality, diagnosis, and management of abnormal uterine bleeding.
- Significance of incidentally thick endometrial echo on transvaginal ultrasound in postmenopausal women.
- Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes.
- Reflections on Beryl Benacerraf.
- Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement.
- Modern evaluation of the endometrium.
- Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
- Selective estrogen receptor modulator: the saga continues.
- The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium.
- Raloxifene use in clinical practice: efficacy and safety.
- Ultrasound scanning in reproductive medicine and infertility. Preface.
- Early pregnancy: normal and abnormal.
- To the editor. Use of transvaginal ultrasonography and sonohysterography.
- Electrical impedance scanning as a new breast cancer risk stratification tool for young women.
- Accreditation, certification: why all the confusion?
- Predicting uterine weight before hysterectomy: ultrasound measurements vs clinical assessment.
- Raloxifene vs tamoxifen.
- Abnormal uterine bleeding: the role of ultrasound.
- Not all SERMs are created equal.
- Attempt to reduce the progestogen component in hormone therapy.
- The complexity of a "complex mass" and the simplicity of a "simple cyst".
- Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen.
- The case for less-than-monthly progestogen in women on HT: is transvaginal ultrasound the key?
- The endometrial echo revisited: have we created a monster?
- Transvaginal ultrasound-assisted gynecologic surgery: evaluation of a new device to improve safety of intrauterine surgery.
- Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study.
- Controversy about uterine effects and safety of SERMs: the saga continues.
- Routine use of office gynecologic ultrasound.
- The effect of raloxifene on the incidence of ovarian cancer in postmenopausal women.
- Evaluation of endometrial polyps.
- ACOG technology assessment in obstetrics and gynecology. Number 3, September 2003. Saline infusion sonohysterography.
- Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement.
- Menorrhagia and abnormal bleeding before the menopause.
- Raloxifene effect on frequency of surgery for pelvic floor relaxation.
- Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement.
- A pharmacological review of selective oestrogen receptor modulators.
- Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women.
- Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding.
- A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium.
- Use of transvaginal ultrasonography to monitor the effects of tamoxifen on uterine leiomyoma size and ovarian cyst formation.
- Transrectal scanning: an alternative when transvaginal scanning is not feasible.
- Lasofoxifene in postmenopausal women with osteoporosis.
- Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health.
- Not all selective estrogen response modulators are created equal: update on lasofoxifene.
- Drugs for the gynecologist to prescribe in the prevention of breast cancer: current status and future trends.
- Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding.
- Evaluation of abnormal vaginal bleeding in perimenopausal women with endovaginal ultrasound and saline infusion sonohysterography.
- The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
- Embryonic death in early pregnancy: a new look at the first trimester.
- An updated protocol for abortion surveillance with ultrasound and immediate pathology.
- Endovaginal ultrasonographic measurement of early embryonic size as a means of assessing gestational age.
- Use of endovaginal ultrasound in the overall gynecologic examination.
- Combined sonographic-pathologic surveillance in elective first-trimester termination of pregnancy.
- Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen.
- Incorporating endovaginal ultrasonography into the overall gynecologic examination.
- Very early pregnancy detection with endovaginal ultrasound.
- Use of ultrasonohysterography for triage of perimenopausal patients with unexplained uterine bleeding.
- The postmenopausal cystic adnexal mass: the potential role of ultrasound in conservative management.
- The presence of endometrial fluid in asymptomatic postmenopausal women is associated with clinically relevant cervical stenosis.
- Effect of raloxifene on the endometrium: will this be the ultimate key to its utilization?
- Saline infusion sonohysterography.
- Estimation of nongravid uterine volume based on a nomogram of gravid uterine volume: its value in gynecologic uterine abnormalities.
- Postmenopausal adnexal cysts: how clinical management has evolved.
- Endometrial safety during hormone replacement therapy: comparison of transvaginal sonography and endometrial biopsy.
- Alterations in steroid hormone receptors in the tamoxifen-treated endometrium.
- Postmenopausal endometrial fluid collections revisited: look at the doughnut rather than the hole.
- The effect of SERMs on the endometrium.
- Effect of SERMs on breast tissue.
- Transvaginal sonographic technique: targeted organ scanning without resorting to "planes".
- Update on raloxifene to prevent endometrial-breast cancer.
- Early detection of pathologic pregnancy by transvaginal sonography.
- Ultrasonographic evaluation of patients with abnormal bleeding.
- Sonography in early pregnancy failure.
- Significance of cardiac activity on endovaginal ultrasound in very early embryos.
- Correlation between karyotype and ultrasound findings in patients with failed early pregnancy.
- Endometrial fluid accumulation in postmenopausal women.
- Transvaginal sonographic detection of the pseudogestational sac associated with ectopic pregnancy.
- Endometrial changes assessed by transvaginal sonography.
- Further attempts to refine our diagnostic capabilities in potential ectopic pregnancies.
- Embryonic ultrasonographic measurements: crown-rump length revisited.
- The routine use of ultrasound in the gynecological visit.
- Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome.
- Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endome...
- Vaginal probe ultrasonography and ectopic pregnancy.
Schools
University Of ChicagoThe Pritzker School Of Medicine
University of Chicago
Johns Hopkins
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Bell's Palsy
- View All
Doctors Specialties
- Internal Medicine
- Neurology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- 1st Place Winner Best of the Best Video Journal of Ob Gyn
- Outstanding Paper in Obstetrics
- Samuel Soffer Award - Outstanding Student in Urology
- Austen Colgate Scholar
- Who's Who
- Honors in Biology
- Phi Beta Kappa
- Fellow (FACOG)
- Super Doctor
Education
-
New York University -
NYU School of Medicine
Hospital
-
NYU Langone Medical Center
Drug Facts
| NPI NUMBER | 1992730600 | |
| NPPES Provider LastName | GOLDSTEIN | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 770895737 | |
| NPPES Provider State | TX | |
| Specialty Description | Neurology | |
| Total Claim Count | 681.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 33.0 | |
| Percent Opioid Claims | 4.85 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992730600 |
| Last Name Of The Provider | GOLDSTEIN |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
Dr. Vinay K. Puduvalli, MD |
|
|
Dr. Jaime D. Cuervo, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Flavia Nelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin A. Whitney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa K. Torres, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tien-Chun Chen, MD |
|
Dr. David E. Zepeda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dolar S. Patolia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernesto Infante, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan A. Garza, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Pamela D. Berens, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Syed H. Reza, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Howard L. Schreiber, MD |
|
|
Dr. John F. Degroot, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amanda L. Jagolino, MD |
|
|
Dr. Wendi B. Monthy, MD
This Doctor is OpenDoctor Recommended.
|